PPT-Suspected Drug-Induced SLE, APLS and ANCA Vasculitis

Author : pamela | Published Date : 2022-02-15

Rheumatology winter clinical symposium 2019 Nina narasimhalu md CASE PRESENTATION 33yearold male presents with bilateral lower extremity edema progressive myalgias

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Suspected Drug-Induced SLE, APLS and ANC..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Suspected Drug-Induced SLE, APLS and ANCA Vasculitis: Transcript


Rheumatology winter clinical symposium 2019 Nina narasimhalu md CASE PRESENTATION 33yearold male presents with bilateral lower extremity edema progressive myalgias generalized weakness periorbital swelling and rash for 2 weeks. atrogenic and Drug-Induced ypertensionEhud Grossman, and Franz H. Messerli, G. A. Mansoor (. Grace). Melanie Kong. Jeremy Ng. Tina Ngo. Causes and Treatment of Granulomatosis with . Polyangiitis. PHM142H1. October 11, 2016. PHM142 Fall . 2016. Coordinator. : Dr. Jeffrey Henderson. Instructor: Dr. David Hampson. vasculitides. . Dr. . Aditya. . Jindal. 5/8/11. The . vasculitides. are a set of related disorders . characterized by . blood vessel . inflammation . leading to tissue or . end-organ injury. Overview and Differential Diagnosis . Mark A. McQuillan MD FACP SFHM. June 15, 2016. DISCLOSURES. None. Blake Roessler MD. David A. Fox, Division Chief. W. Joseph McCune. Ruba Kado MD. Josef Holoshitz MD. Introduction. Epidemiology . Drug-induced Aplastic anemia. Drug-induced Hemolytic anemia. Drug-induced Neutropenia and Agranulocytosis. Drug-induced Thrombocytopenia. Drug-induced Megaloblastic anemia. Mark A. McQuillan MD FACP SFHM. June 15, 2016. DISCLOSURES. None. Blake Roessler MD. David A. Fox, Division Chief. W. Joseph McCune. Ruba Kado MD. Josef Holoshitz MD. UMHS Rheumatology. William . Repaskey. The clinical features of the various . vasculitides. are protean and largely depend on the vascular bed affected (e.g., CNS vs. heart vs. small bowel). . Besides the findings referable to the specific tissues involved, the clinical manifestations typically include constitutional signs and symptoms such as fever, . OF AN . INFLAMMATORY CASE. DR NASIR FAROOQ BUTT. ASSISTANT PROFESSOR. DEPARTMENT OF MEDICINE . KING EDWARD MEDICAL UNIVERSITY. MAYO HOSPITAL LAHORE . INVESTIGATIONS . & MANAGEMENT. CASE . SCENARIOS. Signs and symptoms:. 1- . local. :. according. to the involved tissue. 2- . systemic. :(fever, . myalgia. , . arthralgias. , and malaise). Pathogenesis . 1- immune-mediated inflammation. . 2- . infectious pathogens. ethodology, facilitate therapeutic trials and harmonise the treatment of vasculitis within the EC. A first r ANCA-associated system d its renal-limited variant, renal-lim M - generalised disease and (not always required) may reveal:. · . linear IgG staining along BM (. anti-GBM. ). · . granular immune complex deposition (SLE & rheum dx). · . pauci. immune. . (no Ig, immune complex) . PRESENTER- Dr. B. PRADEEP.. CHAIR PERSON- Dr. T. SMRUTHI.. Vasculitis are group of disorders characterized by . immunoinflammatory. injury to vessel wall . leading to aneurysm, bleeding, stenosis, occlusion, thrombosis, embolism and ischemia. . . JHB Health . District . 27. th. September. . 2023. Hethel Chouhan. Side effects experienced at Jhb Health Facilities. EXAMPLES OF ADRs . REPORTED . Type of report. Suspected drugs. Reaction. outcome. Sophia Lionaki. As. Professor in Nephrology. Department of Nephrology, University Hospital . Attikon. National and . Kapodistrian. University of Athens, Greece. Kidney involvement in ANCA-vasculitis.

Download Document

Here is the link to download the presentation.
"Suspected Drug-Induced SLE, APLS and ANCA Vasculitis"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents